Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Selling General And Administration | 1.9M | 286,227 | 1.4M | 265,825 | 296,718 | -- |
| General And Administrative Expense | 1.8M | 190,153 | 1.3M | 240,042 | 282,849 | -- |
| Research And Development | 0.00 | -- | -- | -- | 0.00 | -- |
| Other Operating Expenses | 584,894 | 817,886 | 332,581 | 468,606 | 347,195 | -- |
| Operating Expense | 2.5M | 1.1M | 1.7M | 669,864 | 643,913 | -- |
| Operating Income | -2.5M | -1.1M | -1.7M | -669,864 | -643,913 | -- |
| EBIT | -2.5M | -1.1M | -1.7M | -669,864 | -643,913 | -- |
| Interest Income | 10,205 | 13,716 | 0.00 | 1.00 | 2.00 | -- |
| Interest Income Non Operating | 10,205 | 13,716 | 0.00 | 1.00 | 2.00 | -- |
| Net Interest Income | 10,205 | 13,716 | 0.00 | 1.00 | 2.00 | -- |
| Other Income Expense | -18,906 | -3,014 | 25,453 | -2.2M | 31,855 | -- |
| Special Income Charges | 0.00 | 0.00 | 36,978 | -- | 0.00 | 0.00 |
| Gain On Sale Of Security | -18,906 | -3,014 | -11,525 | -106,486 | 31,855 | -- |
| Pretax Income | -2.5M | -1.1M | -1.7M | -2.9M | -612,056 | -- |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Net Income From Continuing And Discontinued Operation | -2.5M | -1.1M | -1.7M | -2.9M | -612,056 | -- |
| Net Income From Continuing Operation Net Minority Interest | -2.5M | -1.1M | -1.7M | -2.9M | -612,056 | -- |
| Net Income Including Noncontrolling Interests | -2.5M | -1.1M | -1.7M | -2.9M | -612,056 | -- |
| Net Income Common Stockholders | -2.5M | -1.1M | -1.7M | -2.9M | -612,056 | -- |
| Net Income | -2.5M | -1.1M | -1.7M | -2.9M | -612,056 | -- |
| EBITDA | -2.5M | -1.1M | -1.7M | -669,864 | -643,913 | -- |
| Normalized EBITDA | -2.5M | -1.1M | -1.8M | 1.5M | -675,768 | -- |
| Basic EPS | -0.01 | -0.01 | -0.01 | -- | -0.01 | -0.01 |
| Diluted EPS | -0.01 | -0.01 | -0.01 | -- | -0.01 | -0.01 |
| Basic Average Shares | 217.2M | 203.6M | 125.0M | -- | 99.0M | 99.0M |
| Diluted Average Shares | 217.2M | 203.6M | 125.0M | -- | 99.0M | 99.0M |
| Total Unusual Items | -18,906 | -3,014 | 25,453 | -2.2M | 31,855 | -- |
| Total Unusual Items Excluding Goodwill | -18,906 | -3,014 | 25,453 | -2.2M | 31,855 | -- |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Normalized Income | -2.5M | -1.1M | -1.7M | -669,863 | -643,911 | -- |
| Diluted NI Availto Com Stockholders | -2.5M | -1.1M | -1.7M | -2.9M | -612,056 | -- |
| Net Income Continuous Operations | -2.5M | -1.1M | -1.7M | -2.9M | -612,056 | -- |
| Net Non Operating Interest Income Expense | 10,205 | 13,716 | 0.00 | 1.00 | 2.00 | -- |
| Other Gand A | 99,500 | 55,608 | 87,139 | 142,983 | 60,893 | -- |
| Other Special Charges | -- | -- | -36,978 | -- | -- | -- |
| Salaries And Wages | 1.7M | 134,545 | 1.3M | 97,059 | 221,956 | -- |
| Selling And Marketing Expense | 53,992 | 96,074 | 54,257 | 25,783 | 13,869 | -- |
| Total Expenses | 2.5M | 1.1M | 1.7M | 669,864 | 643,913 | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | 16.0M | 1.7M | 2.9M | 28,949 | 44,351 | -- |
| Cash Cash Equivalents And Short Term Investments | 16.0M | 1.7M | 2.9M | 28,949 | 44,351 | -- |
| Cash Financial | 16.0M | 1.7M | 2.9M | 28,949 | 44,351 | -- |
| Receivables | 321,327 | 271,577 | 264,800 | 89,172 | 82,329 | -- |
| Prepaid Assets | 48,000 | 38,830 | 54,660 | 6,213 | 0.00 | -- |
| Current Assets | 16.4M | 2.0M | 3.2M | 124,334 | 126,680 | -- |
| Net PPE | 270,427 | 187,410 | 187,410 | 187,410 | 2.3M | -- |
| Total Non Current Assets | 270,427 | 187,410 | 187,410 | 187,410 | 2.3M | -- |
| Total Assets | 16.6M | 2.2M | 3.4M | 311,744 | 2.4M | -- |
| Accounts Payable | -- | -- | 159,549 | -- | -- | -- |
| Payables | -- | -- | 303,911 | -- | -- | -- |
| Payables And Accrued Expenses | 670,678 | 157,696 | 303,911 | 1.6M | 890,322 | -- |
| Current Liabilities | 670,678 | 157,696 | 303,911 | 1.6M | 890,322 | -- |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Total Liabilities Net Minority Interest | 670,678 | 157,696 | 303,911 | 1.6M | 890,322 | -- |
| Common Stock | 50.2M | 35.3M | 35.3M | 30.3M | 30.0M | -- |
| Capital Stock | 50.2M | 35.3M | 35.3M | 30.3M | 30.0M | -- |
| Additional Paid In Capital | -- | 6.6M | 6.6M | 5.5M | 5.8M | 5.6M |
| Retained Earnings | -42.4M | -39.9M | -38.8M | -37.1M | -34.2M | -- |
| Common Stock Equity | 16.0M | 2.1M | 3.1M | -1.3M | 1.5M | -- |
| Stockholders Equity | 16.0M | 2.1M | 3.1M | -1.3M | 1.5M | -- |
| Total Equity Gross Minority Interest | 16.0M | 2.1M | 3.1M | -1.3M | 1.5M | -- |
| Total Capitalization | 16.0M | 2.1M | 3.1M | -1.3M | 1.5M | -- |
| Net Tangible Assets | 16.0M | 2.1M | 3.1M | -1.3M | 1.5M | -- |
| Tangible Book Value | 16.0M | 2.1M | 3.1M | -1.3M | 1.5M | -- |
| Working Capital | 15.7M | 1.9M | 2.9M | -1.5M | -763,642 | -- |
| Invested Capital | 16.0M | 2.1M | 3.1M | -1.3M | 1.5M | -- |
| Share Issued | 275.0M | 203.9M | 203.5M | 101.2M | 99.0M | -- |
| Ordinary Shares Number | 275.0M | 203.9M | 203.5M | 101.2M | 99.0M | -- |
| Dueto Related Parties Current | -- | -- | 144,362 | -- | -- | -- |
| Other Equity Interest | 8.1M | -- | -- | -- | -- | -- |
| Other Receivables | 196,456 | 190,202 | 187,064 | 15,620 | 12,594 | -- |
| Taxes Receivable | 124,871 | 81,375 | 77,736 | 73,552 | 69,735 | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -363,968 | -1.2M | -1.8M | -15,402 | -30,360 | -- |
| Cash Flow From Continuing Operating Activities | -363,968 | -1.2M | -1.8M | -15,402 | -30,360 | -- |
| Stock Based Compensation | 1.7M | 42,344 | 1.2M | 88,419 | 188,535 | -- |
| Change In Working Capital | 454,062 | -116,988 | -1.3M | 672,528 | 393,161 | -- |
| Change In Receivables | -58,920 | 9,053 | -39,075 | -13,056 | -9,949 | -- |
| Change In Payables And Accrued Expense | 512,982 | -126,041 | -1.3M | 685,584 | 403,110 | -- |
| Capital Expenditure | -- | -- | -- | -- | -- | -81,764 |
| Purchase Of PPE | -83,017 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Net PPE Purchase And Sale | -83,017 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Investing Cash Flow | -83,017 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Cash Flow From Continuing Investing Activities | -83,017 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Issuance Of Capital Stock | 15.0M | 0.00 | 4.8M | 0.00 | 0.00 | -- |
| Net Common Stock Issuance | 15.0M | 0.00 | 4.8M | 0.00 | 0.00 | -- |
| Financing Cash Flow | 14.7M | 33,505 | 4.7M | 0.00 | 0.00 | -- |
| Cash Flow From Continuing Financing Activities | 14.7M | 33,505 | 4.7M | 0.00 | 0.00 | -- |
| Changes In Cash | 14.3M | -1.1M | 2.8M | -15,402 | -30,360 | -- |
| Beginning Cash Position | 1.7M | 2.9M | 28,949 | 44,351 | 74,711 | -- |
| End Cash Position | 16.0M | 1.7M | 2.9M | 28,949 | 44,351 | -- |
| Free Cash Flow | -446,985 | -1.2M | -1.8M | -15,402 | -30,360 | -- |
| Common Stock Issuance | 15.0M | 0.00 | 4.8M | 0.00 | 0.00 | -- |
| Net Income From Continuing Operations | -2.5M | -1.1M | -1.7M | -2.9M | -612,056 | -- |
| Net Other Financing Charges | -962,047 | -22,745 | -137,937 | 0.00 | 0.00 | -- |
| Proceeds From Stock Option Exercised | 680,550 | 56,250 | 11,250 | -- | 0.00 | 0.00 |